重组杆状病毒RHDV2-VP1疫苗诱导兔抗RHDV2的体液与细胞免疫应答特征
本研究在兔中比较重组杆状病毒RHDV2-VP1疫苗与常规肝脏来源RHDV2疫苗,评估免疫保护起效时间、持续时间和交叉保护及免疫机制。结果显示单次接种后7天即产生保护,至少持续14个月,首免后21天加强免疫对长期保护有负面影响,对RHDV1交叉保护有限,仅50%接种兔存活。
要点
- 单次接种RHDV2-VP1疫苗后7天即诱导保护性免疫应答。
- 该疫苗完全保护至少14个月,但首免后21天加强免疫对长期保护有负面影响。
- 对经典RHDV1交叉保护有限,仅50%接种兔在感染后存活。
核心结论
- 重组杆状病毒RHDV2-VP1疫苗有潜力保护兔免受RHDV2感染,完全阻断疾病进展并在群体水平阻止RHDV2传播。
研究设计与样本
- 在兔中开展实验研究,将重组RHDV2-VP1疫苗与常规肝脏来源RHDV2疫苗进行比较。
- 评估指标包括保护起效时间、保护持续时间、对经典RHDV1的交叉保护以及体液和细胞免疫机制。
主要发现
- 单次接种RHDV2-VP1疫苗后7天即诱导保护性免疫应答。
- 该疫苗提供完全保护至少14个月。
- 首免后21天加强免疫对长期保护有负面影响。
- 对经典RHDV1交叉保护有限,仅50%接种兔在感染后存活。
临床怎么用
- 针对RHDV2的免疫预防可考虑使用重组杆状病毒RHDV2-VP1疫苗,单次接种后7天即具保护力。
- 该疫苗长期保护至少14个月,但应避免在首免后21天加强免疫以免影响长期保护。
- 对经典RHDV1的交叉保护有限,仅50%接种兔存活,不能依赖该疫苗完全预防RHDV1。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rabbit hemorrhagic disease (RHD) is a lethal disease in rabbits caused by RHD virus (RHDV). Protection is only possible through vaccination. A new virus variant (RHDV2) which emerged in 2010 in France differed from the classical RHDV1 variant in certain aspects and vaccines against RHDV1 induced limited cross protection only. In a previous study, we designed a recombinant baculovirus based RHDV2-VP1 vaccine, which provided a protective immunity in rabbits against RHDV2. In the present study this newly created vaccine is characterized with regard to onset and duration of protection, and possible cross protection against classical RHDV1. Furthermore, humoral and cellular immune mechanisms in vaccinated and infected rabbits were analyzed. In all experiments, the recombinant vaccine was compared to a conventional liver-based RHDV2 vaccine. The RHDV2-VP1 vaccine induced a protective immune response already seven days after single vaccination and fully protected for at least 14 months. A booster vaccination 21 days after the first had a negative influence on long-term protection. The cross protection provided by the RHDV2-VP1 vaccine against classical RHDV1 was limited since only 50% of vaccinated rabbits survived the infection. Conclusively, the new, baculovirus-based RHDV2-VP1 vaccine has the potential to protect rabbits against the infection with RHDV2, blocks completely the disease progression and prevents the spread of RHDV2 at the population level.
引用
- Müller C, Ulrich R, Schinköthe J, et al. Characterization of protective humoral and cellular immune responses against RHDV2 induced by a new vaccine based on recombinant baculovirus. Vaccine. 2019. PMID: 31182325. doi:10.1016/j.vaccine.2019.04.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。